位置:首页 > 蛋白库 > EXSC_PSEAE
EXSC_PSEAE
ID   EXSC_PSEAE              Reviewed;         145 AA.
AC   P26995;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   03-AUG-2022, entry version 109.
DE   RecName: Full=Transcriptional anti-antiactivator ExsC;
GN   Name=exsC; OrderedLocusNames=PA1710;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=1655713; DOI=10.1128/jb.173.20.6460-6468.1991;
RA   Frank D.W., Iglewski B.H.;
RT   "Cloning and sequence analysis of a trans-regulatory locus required for
RT   exoenzyme S synthesis in Pseudomonas aeruginosa.";
RL   J. Bacteriol. 173:6460-6468(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=9045825; DOI=10.1128/jb.179.5.1646-1654.1997;
RA   Goranson J., Hovey A.K., Frank D.W.;
RT   "Functional analysis of exsC and exsB in regulation of exoenzyme S
RT   production by Pseudomonas aeruginosa.";
RL   J. Bacteriol. 179:1646-1654(1997).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, INTERACTION WITH EXSD, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15225323; DOI=10.1111/j.1365-2958.2004.04128.x;
RA   Dasgupta N., Lykken G.L., Wolfgang M.C., Yahr T.L.;
RT   "A novel anti-anti-activator mechanism regulates expression of the
RT   Pseudomonas aeruginosa type III secretion system.";
RL   Mol. Microbiol. 53:297-308(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH EXSD.
RX   PubMed=16980486; DOI=10.1128/jb.00884-06;
RA   Lykken G.L., Chen G., Brutinel E.D., Chen L., Yahr T.L.;
RT   "Characterization of ExsC and ExsD self-association and heterocomplex
RT   formation.";
RL   J. Bacteriol. 188:6832-6840(2006).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16714561; DOI=10.1128/iai.00090-06;
RA   Dasgupta N., Ashare A., Hunninghake G.W., Yahr T.L.;
RT   "Transcriptional induction of the Pseudomonas aeruginosa type III secretion
RT   system by low Ca2+ and host cell contact proceeds through two distinct
RT   signaling pathways.";
RL   Infect. Immun. 74:3334-3341(2006).
RN   [7]
RP   SUBUNIT, INTERACTION WITH EXSE AND EXSD, AND ACTIVITY REGULATION.
RX   PubMed=17197437; DOI=10.1074/jbc.m611664200;
RA   Zheng Z., Chen G., Joshi S., Brutinel E.D., Yahr T.L., Chen L.;
RT   "Biochemical characterization of a regulatory cascade controlling
RT   transcription of the Pseudomonas aeruginosa type III secretion system.";
RL   J. Biol. Chem. 282:6136-6142(2007).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1-131, AND INTERACTION WITH EXSE.
RX   PubMed=20536183; DOI=10.1021/bi100432e;
RA   Vogelaar N.J., Jing X., Robinson H.H., Schubot F.D.;
RT   "Analysis of the crystal structure of the ExsC.ExsE complex reveals
RT   distinctive binding interactions of the Pseudomonas aeruginosa type III
RT   secretion chaperone ExsC with ExsE and ExsD.";
RL   Biochemistry 49:5870-5879(2010).
CC   -!- FUNCTION: Part of the regulatory cascade that plays a role in the
CC       transcriptional regulation of the type III secretion system (T3SS)
CC       (PubMed:16714561, PubMed:9045825). Interacts with antiactivator ExsD to
CC       inhibit its activity leading to ExsA-mediated transcription
CC       (PubMed:15225323, PubMed:16980486). {ECO:0000269|PubMed:15225323,
CC       ECO:0000269|PubMed:16714561, ECO:0000269|PubMed:16980486,
CC       ECO:0000269|PubMed:9045825}.
CC   -!- ACTIVITY REGULATION: In the absence of inducing signals, ExsE interacts
CC       with and inhibits ExsC activity. {ECO:0000269|PubMed:17197437}.
CC   -!- SUBUNIT: Homodimer (PubMed:17197437). Interacts with ExsE
CC       (PubMed:17197437, PubMed:20536183). Interacts directly with ExsD to
CC       form a heterotetrameric complex (PubMed:17197437, PubMed:15225323,
CC       PubMed:16980486). {ECO:0000269|PubMed:15225323,
CC       ECO:0000269|PubMed:16980486, ECO:0000269|PubMed:17197437,
CC       ECO:0000269|PubMed:20536183}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15225323}.
CC   -!- DISRUPTION PHENOTYPE: Deletion mutant results in a two to three-fold
CC       reduction in extracellular exoenzyme S activity representing the
CC       efficiency of type III secretion system (T3SS) (PubMed:9045825,
CC       PubMed:15225323). Mutant also demonstrates a lag in the induction of
CC       cytotoxicity towards Chinese hamster ovary cells and is attenuated for
CC       virulence in a mouse pneumonia model (PubMed:16714561).
CC       {ECO:0000269|PubMed:15225323, ECO:0000269|PubMed:16714561,
CC       ECO:0000269|PubMed:9045825}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M64975; AAA25814.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG05099.1; -; Genomic_DNA.
DR   PIR; A41047; A41047.
DR   RefSeq; NP_250401.1; NC_002516.2.
DR   RefSeq; WP_003100769.1; NZ_QZGE01000003.1.
DR   PDB; 3KXY; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-131.
DR   PDBsum; 3KXY; -.
DR   AlphaFoldDB; P26995; -.
DR   SMR; P26995; -.
DR   IntAct; P26995; 1.
DR   STRING; 287.DR97_177; -.
DR   PaxDb; P26995; -.
DR   PRIDE; P26995; -.
DR   DNASU; 878452; -.
DR   EnsemblBacteria; AAG05099; AAG05099; PA1710.
DR   GeneID; 878452; -.
DR   KEGG; pae:PA1710; -.
DR   PATRIC; fig|208964.12.peg.1772; -.
DR   PseudoCAP; PA1710; -.
DR   HOGENOM; CLU_1785211_0_0_6; -.
DR   OMA; TQSESWE; -.
DR   BioCyc; PAER208964:G1FZ6-1741-MON; -.
DR   EvolutionaryTrace; P26995; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:PseudoCAP.
DR   GO; GO:0030254; P:protein secretion by the type III secretion system; IMP:PseudoCAP.
DR   InterPro; IPR010261; Tir_chaperone.
DR   Pfam; PF05932; CesT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Reference proteome.
FT   CHAIN           1..145
FT                   /note="Transcriptional anti-antiactivator ExsC"
FT                   /id="PRO_0000021219"
FT   HELIX           3..18
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   STRAND          29..35
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   TURN            36..38
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   STRAND          39..46
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   TURN            47..50
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   STRAND          51..60
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   HELIX           68..77
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   HELIX           78..81
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   STRAND          85..88
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   TURN            90..92
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   STRAND          94..102
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   TURN            103..105
FT                   /evidence="ECO:0007829|PDB:3KXY"
FT   HELIX           108..128
FT                   /evidence="ECO:0007829|PDB:3KXY"
SQ   SEQUENCE   145 AA;  16229 MW;  A53BEB27270EA737 CRC64;
     MDLTSKVNRL LAEFAGRIGL PSLSLDEEGM ASLLFDEQVG VTLLLLAERE RLLLEADVAG
     IDVLGEGIFR QLASFNRHWH RFDLHFGFDE LTGKVQLYAQ ILAAQLTLEC FEATLANLLD
     HAEFWQRLLP CDSDREAVAA VGMRV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024